Barbara SambucoVP Operations, Drug Product, Biotherapeutics at Catalent
Barbara Sambuco is the VP of Operations, Drug Product, Biotherapeutics, with years of experience in product development, quality, and operations. Ms. Sambuco has been the General Manager of Catalent’s oral solid, sterile and biologic site in Anagni, Italy. Ms. Sambuco joined Catalent following its acquisition of the Anagni site from Bristol-Myers Squibb where she spent 14 years leading different teams within the site as the General Manager, Manufacturing Technology Director, QC Director and Operations Director. Prior to Bristol-Myers Squibb she held leadership positions at Chiesi Farmaceutici, Hoechst and CTP, a pharmaceutical consultant company. Ms. Sambuco received her Bachelor in Chemistry and a Master in Biotechnology from the University of Rome “La Sapienza”.